April 23rd 2025
The investment will be done over five years and will include new, state-of-the-art R&D facilities as well as new or expanded manufacturing sites in multiple US states.
NGS abbreviates drug discovery timelines.
Characterizing Critical Quality Attributes in Biopharmaceutical Drug Development
September 1st 2018Andrew Bulpin, head of Process Solutions, MilliporeSigma, shares insights on characterizing CQAs in biopharmaceutical development and the different tests that should be carried out when assessing an investigational drug.
Solutions and Solvents Improve Analytical Instrument Performance
August 29th 2018Flush solutions for liquid chromatography mass spectrometry (LC-MS) systems and ultrapure solvents for ultra-high-performance LC-MS systems from Thermo Fisher Scientific can minimize interference and maximize lab instrument uptime.